Approval process stalls for generic biologics: FDA forms committee to solicit comments from experts and the general public on safety concerns.(RHEUMATOLOGY): An article from: Internal Medicine News

This digital document is an article from Internal Medicine News, published by International Medical News Group on September 15, 2010. The length of the article is 1407 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Approval process stalls for generic biologics: FDA forms committee to solicit comments from experts and the general public on safety concerns.(RHEUMATOLOGY)
Author: Denise Napoli
Publication:Internal Medicine News (Magazine/Journal)
Date: September 15, 2010
Publisher: International Medical News Group
Volume: 43 Issue: 15 Page: 29(1)

Distributed by Gale, a part of Cengage Learning